Evolve Private Wealth LLC Takes $546,000 Position in Chemed Corporation $CHE

Evolve Private Wealth LLC purchased a new position in shares of Chemed Corporation (NYSE:CHE) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 1,173 shares of the company’s stock, valued at approximately $546,000.

Several other hedge funds have also recently added to or reduced their stakes in CHE. TD Asset Management Inc grew its holdings in shares of Chemed by 7.5% during the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after buying an additional 22,715 shares in the last quarter. BNP Paribas Financial Markets boosted its holdings in shares of Chemed by 14.5% during the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock worth $14,985,000 after purchasing an additional 4,430 shares during the last quarter. Epoch Investment Partners Inc. grew its position in shares of Chemed by 4.9% in the fourth quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock valued at $137,945,000 after purchasing an additional 15,133 shares in the last quarter. C WorldWide Group Holding A S purchased a new stake in shares of Chemed in the fourth quarter valued at approximately $2,189,000. Finally, Norges Bank purchased a new stake in shares of Chemed in the fourth quarter valued at approximately $76,067,000. 95.85% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Royal Bank Of Canada lifted their target price on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 30th. Oppenheimer lifted their target price on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research note on Friday, July 31st. Finally, Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $530.75.

Chemed Stock Performance

NYSE CHE opened at $540.18 on Tuesday. The stock has a market cap of $7.06 billion, a PE ratio of 27.13, a P/E/G ratio of 2.05 and a beta of 0.51. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00. The stock has a fifty day simple moving average of $501.57 and a 200-day simple moving average of $447.26.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. During the same period in the previous year, the firm earned $4.27 EPS. Chemed’s revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be given a $0.70 dividend. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 annualized dividend and a yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s dividend payout ratio is presently 14.06%.

Insider Buying and Selling at Chemed

In other news, Director Patrick P. Grace sold 190 shares of the firm’s stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the transaction, the director owned 3,533 shares of the company’s stock, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Spencer S. Lee sold 1,000 shares of the business’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $541.04, for a total transaction of $541,040.00. Following the completion of the transaction, the executive vice president owned 13,912 shares of the company’s stock, valued at approximately $7,526,948.48. This trade represents a 6.71% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 6,537 shares of company stock valued at $3,406,014 over the last three months. 3.33% of the stock is currently owned by company insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.